Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.

Autor: Neller MA; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Ambalathingal GR; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Hamad N; Department of Haematology, St Vincent's Hospital, School of Clinical Medicine, University of New South Wales and School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia., Sasadeusz J; Department of Haematology, St Vincent's Hospital, School of Clinical Medicine, University of New South Wales and School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia., Pearson R; Department of Haematology, St Vincent's Hospital, School of Clinical Medicine, University of New South Wales and School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia., Holmes-Liew CL; Royal Adelaide Hospital, Adelaide, South Australia, Australia., Singhal D; Royal Adelaide Hospital, Adelaide, South Australia, Australia., Tunbridge M; Royal Adelaide Hospital, Adelaide, South Australia, Australia., Ng WY; Royal Adelaide Hospital, Adelaide, South Australia, Australia., Sharplin K; Royal Adelaide Hospital, Adelaide, South Australia, Australia., Moore A; Queensland Children's Hospital, South Brisbane, Queensland, Australia., Deambrosis D; Queensland Children's Hospital, South Brisbane, Queensland, Australia., Soosay-Raj T; Queensland Children's Hospital, South Brisbane, Queensland, Australia., McNaughton P; Queensland Children's Hospital, South Brisbane, Queensland, Australia., Whyte M; Queensland Children's Hospital, South Brisbane, Queensland, Australia., Fraser C; Queensland Children's Hospital, South Brisbane, Queensland, Australia., Grigg A; Austin Hospital, Heidelberg, Victoria, Australia., Kliman D; Royal North Shore Hospital, St Leonards, New South Wales, Australia., Bajel A; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Cummins K; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Dowling M; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Yeoh ZH; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Harrison SJ; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Khot A; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Tan S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Roos I; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Koo RM; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Dohrmann S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Ritchie D; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Wainstein B; Sydney Children's Hospital, Randwick, New South Wales, Australia., McCleary K; Sydney Children's Hospital, Randwick, New South Wales, Australia., Nelson A; Sydney Children's Hospital, Randwick, New South Wales, Australia., Gardiner B; The Alfred Hospital, Melbourne, Victoria, Australia., Inam S; The Alfred Hospital, Melbourne, Victoria, Australia., Badoux X; St George Public Hospital, Kogarah, New South Wales, Australia., Ma K; Westmead Hospital, Westmead, New South Wales, Australia., Toro C; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Hanna D; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Hughes D; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Conyers R; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Cole T; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Wang SS; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Chee L; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Fleming J; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Irish A; Fiona Stanley Hospital, Murdoch, Western Australia, Australia., Purtill D; Fiona Stanley Hospital, Murdoch, Western Australia, Australia., Cooney J; Fiona Stanley Hospital, Murdoch, Western Australia, Australia., Shaw P; The Children's Hospital at Westmead, Westmead, New South Wales, Australia., Tey SK; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., Hunt S; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., Subramonia Pillai E; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., John G; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., Ng M; Perth Children's Hospital, Nedlands, Western Australia, Australia., Ramachandran S; Perth Children's Hospital, Nedlands, Western Australia, Australia., Hopkins P; The Prince Charles Hospital, Chermside, Queensland, Australia.; The University of Queensland Medical School, Herston, Queensland, Australia., Chambers D; The Prince Charles Hospital, Chermside, Queensland, Australia., Campbell S; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Francis R; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Isbel N; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Marlton P; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Reddiex H; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Matthews KK; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Voogt M; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Panikkar A; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Beagley L; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Rehan S; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Best S; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Raju J; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Le Texier L; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Crooks P; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Solomon M; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Lekieffre L; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Srihari S; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Smith C; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Khanna R; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. Rajiv.Khanna@qimrberghofer.edu.au.

Publikováno v: Nature communications [Nat Commun] 2024 Dec 03; Vol. 15 (1), pp. 10339. Date of Electronic Publication: 2024 Dec 03.

The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.

Autor: Di Ciaccio PR; Department of Haematology, The Canberra Hospital, Garran, ACT, Australia.; College of Health and Medicine, Australian National University, Canberra, ACT, Australia., Polizzotto MN; Department of Haematology, The Canberra Hospital, Garran, ACT, Australia.; John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Cwynarski K; Department of Haematology, University College Hospital, London, United Kingdom., Gerrie AS; Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, BC, Canada., Burton C; Department of Haematology, St James University Hospital, Leeds, United Kingdom., Bower M; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Kuruvilla J; Division of Oncology and Haematology, Princess Margaret Cancer Centre, The Princess Margaret Hospital, Toronto, ON, Canada., Montoto S; Department of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., McKay P; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Fox CP; University Hospitals NHS Trust, Nottingham, United Kingdom.; School of Medicine, University of Nottingham, Nottingham, United Kingdom., Milliken S; Department of Haematology, St Vincent's Hospital, Sydney, NSW, Australia., Jiamsakul A; The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Osborne W; Department of Haematology, Freeman Hospital, Newcastle upon Tyne NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom., Collins GP; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Manos K; Department of Haematology, Flinders Medical Centre, Adelaide, SA, Australia., Linton KM; The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom.; Manchester Cancer Research Centre, University of Manchester, Manchester, United Kingdom.; Manchester Academic Health Science Centre, Manchester, United Kingdom., Iyengar S; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Kassam S; King's College Hospital, London, United Kingdom., Limei MP; Department of Haematology, National University Hospital, Singapore., Kliman D; Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia., Wong Doo N; Department of Haematology, Concord Repatriation General Hospital, Sydney, NSW, Australia.; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia., Watson AM; Department of Haematology, Liverpool Hospital, Sydney, NSW, Australia., Fedele P; School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.; Haematology Department, Monash Health, Clayton, VIC, Australia., Yannakou CK; Department of Molecular Oncology and Cancer Immunology, Epworth Freemasons Hospital, Epworth HealthCare, Melbourne, Victoria, Australia., Hunt S; Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia., Ku M; Department of Haematology, St Vincent's Hospital, Melbourne, VIC, Australia., Sehn LH; Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, BC, Canada., Smith A; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom., Renshaw H; Department of Haematology, University College Hospital, London, United Kingdom., Maxwell A; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Liu Q; Division of Oncology and Haematology, Princess Margaret Cancer Centre, The Princess Margaret Hospital, Toronto, ON, Canada., Dhairyawan R; Department of Infection and Immunity, Barts Health NHS Trust, London, United Kingdom., Ferguson G; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Pickard K; Department of Haematology, Freeman Hospital, Newcastle upon Tyne NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom., Painter D; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom., Thakrar N; Department of Haematology, University College Hospital, London, United Kingdom., Song KW; Leukemia/Bone Marrow Transplant Program of British Columbia and Division of Hematology, BC Cancer, University of British Columbia, Vancouver, BC, Canada., Hamad N; Department of Haematology, St Vincent's Hospital, Sydney, NSW, Australia.; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia.; School of Medicine, University of Notre Dame, Perth, WA, Australia.

Publikováno v: Blood [Blood] 2024 Jan 11; Vol. 143 (2), pp. 152-165.

Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis.

Autor: Blennerhassett R; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.; School of Clinical Medicine, University of NSW Medicine and Health, Sydney, New South Wales, Australia., Othman J; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia., Biscoe A; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia., Kliman D; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia., Mills G; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.; School of Clinical Medicine, University of NSW Medicine and Health, Sydney, New South Wales, Australia., Blyth E; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, New South Wales, Australia., Micklethwaite K; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, New South Wales, Australia., Kwan J; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, New South Wales, Australia., Bilmon I; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, New South Wales, Australia., Bhattacharyya A; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, New South Wales, Australia., Panicker S; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, New South Wales, Australia., Fay K; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia., Milliken S; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.; School of Clinical Medicine, University of NSW Medicine and Health, Sydney, New South Wales, Australia., Ma D; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.; School of Clinical Medicine, University of NSW Medicine and Health, Sydney, New South Wales, Australia., Hamad N; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.; School of Clinical Medicine, University of NSW Medicine and Health, Sydney, New South Wales, Australia.; School of Medicine, University of Notre Dame Australia, School of Medicine, Sydney, New South Wales, Australia., Stevenson W; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia., Arthur C; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia., Moore J; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.; School of Clinical Medicine, University of NSW Medicine and Health, Sydney, New South Wales, Australia., Greenwood M; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia., Gottlieb D; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, New South Wales, Australia., Kerridge I; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Publikováno v: Internal medicine journal [Intern Med J] 2023 Nov; Vol. 53 (11), pp. 1979-1986. Date of Electronic Publication: 2023 Mar 21.

Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy.

Autor: Dillon HT; Clinical Research Domain, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Institute of Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC, Australia., Foulkes S; Clinical Research Domain, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Institute of Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC, Australia., Horne-Okano YA; Clinical Research Domain, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Kliman D; Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, VIC, Australia., Dunstan DW; Clinical Research Domain, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Institute of Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC, Australia., Daly RM; Institute of Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC, Australia., Fraser SF; Institute of Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC, Australia., Avery S; Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, VIC, Australia., Kingwell BA; Clinical Research Domain, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; CSL Ltd, Melbourne, VIC, Australia., La Gerche A; Clinical Research Domain, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Howden EJ; Clinical Research Domain, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2022 Dec 15; Vol. 9, pp. 926064. Date of Electronic Publication: 2022 Dec 15 (Print Publication: 2022).

Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocol.

Autor: Dillon HT; Baker Heart and Diabetes Institute, Melbourne, Australia. hayley.dillon@baker.edu.au.; Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia. hayley.dillon@baker.edu.au., Saner NJ; Baker Heart and Diabetes Institute, Melbourne, Australia., Ilsley T; Baker Heart and Diabetes Institute, Melbourne, Australia.; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia., Kliman D; Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Australia., Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Australia., Avery S; Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Australia., Dunstan DW; Baker Heart and Diabetes Institute, Melbourne, Australia.; Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia., Daly RM; Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia., Fraser SF; Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia., Owen N; Baker Heart and Diabetes Institute, Melbourne, Australia.; Centre for Urban Transitions, Swinburne University of Technology, Melbourne, Australia., Lynch BM; Baker Heart and Diabetes Institute, Melbourne, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Australia., Kingwell BA; Baker Heart and Diabetes Institute, Melbourne, Australia.; CSL Ltd, Melbourne, Australia., La Gerche A; Baker Heart and Diabetes Institute, Melbourne, Australia., Howden EJ; Baker Heart and Diabetes Institute, Melbourne, Australia.

Publikováno v: BMC cancer [BMC Cancer] 2022 Aug 17; Vol. 22 (1), pp. 898. Date of Electronic Publication: 2022 Aug 17.